Analysis By Organization Size (Small and Medium Organizations and Large Organizations), Offerings (Products, Platforms, and Services), Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products, and Others), Clinical Indication (Cardiovascular Diseases, Neurodegenerative Diseases, Oncology, Rare Diseases, Metabolic Diseases, Immune Based Diseases, Infectious Diseases, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations, and Others)
No. of Pages:153
Report Code:
TIPRE00029247
Category:
Life Sciences
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
The South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is expected to reach US$ 448.1 million by 2028 from US$ 196.1 million in 2021. The market is estimated to grow at a CAGR of 12.5% from 2021 to 2028.
Artificial Intelligence is applied to drug discovery at various points in the development cycle, including data mining, preclinical development, lead discovery, target identification, clinical development, drug safety, and drug repurposing. As to the actual drug production, AI plays a part in digital biomanufacturing, in which data management, data modeling, automation, and AI tools are used for process optimization. Digital twins of bioprocesses have started to gain traction in the biopharmaceutical industry. Laboratory experiments are replaced with in-silico simulations, enabling a relatively inexpensive and fast environment for research and development. Thus, constructive use of AI and machine learning in in-silico trials are currently trending and is expected to boost the growth of the in-silico trial market in coming years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market at a promising CAGR during the forecast period.
South & Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue and Forecast to 2028 (US$ Million)
The market for in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into organization size, offerings, application, clinical indication, and end user. Based on organization size, the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into small and medium organizations and large organizations. Based on offerings, the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into products, platforms, and services. Based on application, the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into product design and discovery, product development, pre-clinical targeting, assessment of drugs and other biomedical products, and others. Based on clinical indication, the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into cardiovascular diseases, neurodegenerative diseases, oncology, rare diseases, metabolic diseases, immune based diseases, infectious diseases, and others. Based on end user, the in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into pharmaceutical and biopharmaceutical companies, medical technology companies, contract research organizations, and others. By country, the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market is segmented into Brazil, Argentina, and the Rest of South & Central America.
Dassault Systèmes SE; Certara Inc.; Ansys, Inc.; and Sensyne Health plc. are among the leading companies in the South & Central America in-silico trials: computational modelling and simulation for medical product innovation and regulatory clearance market.
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Strategic Insights
Get more information on this report
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Segmentation Analysis
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Report Highlights
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Report Scope
Report Attribute
Details
Market size in 2021
US$ 196.1 Million
Market Size by 2028
US$ 448.1 Million
CAGR (2021 - 2028)
12.5%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Organization Size
Small and Medium Organizations and Large Organizations
By Offerings
Products
Platforms
Services
By Application
Product Design and Discovery
Product Development
Pre-Clinical Targeting
Assessment of Drugs and Other Biomedical Products
By Clinical Indication
Cardiovascular Diseases
Neurodegenerative Diseases
Oncology
Rare Diseases
Metabolic Diseases
Immune Based Diseases
Infectious Diseases
Regions and Countries Covered
South and Central America
Brazil
Argentina
Rest of South and Central America
Market leaders and key company profiles
Dassault Systèmes SE
Certara Inc.
Ansys, Inc.
Synopsys, Inc.
Get more information on this report
South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Country and Regional Insights
Get more information on this report
Identical Market Reports with other Region/Countries
The List of Companies - South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
Dassault Systèmes SE
Certara Inc.
Ansys, Inc.
Synopsys, Inc.
Frequently Asked Questions
How big is the South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market?
The South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market is valued at US$ 196.1 Million in 2021, it is projected to reach US$ 448.1 Million by 2028.
What is the CAGR for South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market by (2021 - 2028)?
As per our report South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market, the market size is valued at US$ 196.1 Million in 2021, projecting it to reach US$ 448.1 Million by 2028. This translates to a CAGR of approximately 12.5% during the forecast period.
What segments are covered in this report?
The South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market report typically cover these key segments-
Organization Size (Small and Medium Organizations and Large Organizations)
Offerings (Products, Platforms, Services)
Application (Product Design and Discovery, Product Development, Pre-Clinical Targeting, Assessment of Drugs and Other Biomedical Products)
End User (Pharmaceutical and Biopharmaceutical Companies, Medical Technology Companies, Contract Research Organizations)
What is the historic period, base year, and forecast period taken for South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market report:
Historic Period : 2019-2020
Base Year : 2021
Forecast Period : 2022-2028
Who are the major players in South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market?
The South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Dassault Systèmes SE
Certara Inc.
Ansys, Inc.
Synopsys, Inc.
Who should buy this report?
The South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
Get Free Sample For South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
1. Complete the form
2. Check your inbox (and spam/junk folder)
3. Your Personal Data is Secure with us
GDPR + CCPA Compliant
Personal & transactional information is kept safe from unauthorized use.
Get Free Sample For South and Central America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market
